欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2003, Vol. 8 ›› Issue (3): 356-360.

• 设计与统计 • 上一篇    

临床试验中特殊受试人群选择的国际伦理要求节译自《人体生物医学研究国际伦理指南》(2002 年8 月)

卜擎燕1译, 熊宁宁2, 吴静2校   

  1. 1 南京中医药大学, 南京210029;
    2 南京中医药大学附属医院国家药品临床研究基地, 南京210029
  • 收稿日期:2002-12-27 修回日期:2003-01-08 出版日期:2003-06-26 发布日期:2020-11-25
  • 通讯作者: 熊宁宁, 男, 教授, 主任医师, 主要从事临床药理学研究。Tel Fax;025-6555033, 6506055 E-mail:jsszyyjd@jlonline.com, xiongnin@publi c1.ptt.js.cn
  • 作者简介:卜擎燕, 女, 硕士研究生, 主要从事临床药理学研究。吴静, 女, 医学博士, 主要从事消化系统疾病的临床研究。
  • 基金资助:
    国家科学技术部“ 临床试验关键技术及平台研究” 课题资助(№2002AA2Z341i)

International ethical guidelines for the selection of vulnerable subjects in clinical trials Extracted from CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects

Translated by BO Qing-Yan1, Revised by XIONG Ning-Ning2, WU Jing2   

  1. 1 Nanjing University of Traditional Chinese Medicine, Nanjing 210029, Jiangsu;
    2 National Base for Drug Clinical Trial, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, Jiangsu
  • Received:2002-12-27 Revised:2003-01-08 Online:2003-06-26 Published:2020-11-25

摘要: 弱势人群是指那些相对地(或绝对地) 没有能力维护自身利益的人, 即他们没有足够的权力、智力、教育、财力、力量、或其他必需的属性来保护他们的自身利益。邀请弱势个体作为受试者需要特殊的理由, 如果选择他们, 必须切实履行保护他们权利和健康的措施。本文重点论述了涉及儿童、因智力或行为障碍不能给予充分知情同意者、妇女、孕妇等弱势群体生物医学研究的国际伦理要求。最后谈到研究是负担和利益并存的, 任何群体或个人, 包括弱势人群, 都不应过多承担研究的负担, 但也绝不能被排除在能使其受益的研究之外。

关键词: 医学伦理学, 临床试验, 国际医学科学组织, 指南, 伦理, 弱势人群

Abstract: Vulnerable persons are thosewho are relatively (or absolutely) incapable of protecting their own interests.More formally, they may have insufficient power, intelligence, education, resources, strength, or other needed attributes to protect their own interests.Special justification is required for inviting vulnerable individuals to serve as research subjects and, if they are selected, the means of protecting their rights and welfare must be strictly applied.This article focuses on the international ethical requirements of biomedical research involving children, individuals who by reason of mental or behavioral disorders are not capable of giving adequately informed consent, women, and pregnant women, etc.Finally, it talks about the duality of research, i.e, burden and benefits.No groups and individuals, including vulnerable groups should bear more than its fair share of the burdens of participation in research.Similarly, no group should be deprived of its fair share of the benefits of research.

Key words: medical ethics, clinical trial, Council for International Organizations of Medical Sciences, guideline, ethical, vulnerable groups

中图分类号: